Amlodipine Besylate Tablet
Product Images NDC 70518-4629

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 70518-4629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Amlodipine Besylate 2.5mg 70518 4629 00)

Amlodipine Besylate 2.5 mg tablet packaging label showing quantity of 50 tablets per box. The label includes the NDC number 70518-4629-00, with mention of RemedyRepack Inc. as the repackager located in Indiana, PA. Additional storage instructions and manufacturer details from Ascend Labs, LLC, Montvale, NJ are noted.*

FDA Label Image

Mm3 (Amlodipine Besylate 2.5mg 70518 4629 02)

Amlodipine Besylate 2.5 mg tablets label for a quantity of 30 tablets. The label shows the NDC number 70518-4629-02 and notes the tablets are round, white, and shaped as A2. It is repackaged by RemedyRepack Inc. in Indiana, PA. Storage instructions specify 20-25°C with allowed excursions to 15-30°C. Manufacturer is Ascend Labs, LLC.*

FDA Label Image

Remedy_label (Remedy Label)

Amlodipine Besylate Tablet 2.5 mg label showing quantity of 1 tablet, NDC 70518-4629-01, repackaged by RemedyRepack Inc. in Indiana, PA. The label includes storage instructions, a QR code, and mentions the manufacturer Ascend Labs, LLC. The tablet is described as round and white.*

FDA Label Image

Figure 2 (Amlodipine Fig)

A forest plot chart comparing hazard ratios with 95% confidence intervals between amlodipine and placebo groups across various patient subgroups. Subgroups include age, gender, baseline sitting systolic blood pressure, baseline vessel disease, vessel stenosis, and PCI stent status. The x-axis ranges from 0.0 to 2.0, centering on a hazard ratio of 1.0 representing no difference.*

FDA Label Image

Figure 1 (Amlodipine Gra)

A Kaplan-Meier survival curve illustrating event rates over time (in months) comparing Amlodipine versus placebo. The chart shows event rates on the y-axis and time in months on the x-axis, with the number at risk decreasing over time. Statistical values including p-value, hazard ratio, and 95% confidence interval are provided in a box.*

FDA Label Image

Amlodipine-str-2 (Amlodipine Str 2)

Chemical structure of amlodipine besylate, showing its molecular arrangement including aromatic rings, chlorine substituent, and side chain features typical of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.